Literature DB >> 22094804

cDNA display: rapid stabilization of mRNA display.

Shingo Ueno1, Naoto Nemoto.   

Abstract

The cDNA display method is a robust in vitro display technology that converts an unstable mRNA-protein fusion (mRNA display) to a stable mRNA/cDNA-protein fusion (cDNA display) whose cDNA is covalently linked to its encoded protein using a well-designed puromycin linker. We provide technical details for preparing cDNA display molecules and for the synthesis of the puromycin linker for the purpose of screening the functional proteins and peptides.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22094804     DOI: 10.1007/978-1-61779-379-0_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  In vitro selection of a peptide antagonist of growth hormone secretagogue receptor using cDNA display.

Authors:  Shingo Ueno; Sayaka Yoshida; Anupom Mondal; Kazuya Nishina; Makoto Koyama; Ichiro Sakata; Kenju Miura; Yujiro Hayashi; Naoto Nemoto; Koichi Nishigaki; Takafumi Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-20       Impact factor: 11.205

Review 2.  Peptide aptamers: development and applications.

Authors:  Sergey Reverdatto; David S Burz; Alexander Shekhtman
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

3.  In vitro evolution of enzymes.

Authors:  Misha V Golynskiy; John C Haugner; Aleardo Morelli; Dana Morrone; Burckhard Seelig
Journal:  Methods Mol Biol       Date:  2013

Review 4.  Prospects and challenges of CRISPR/Cas genome editing for the study and control of neglected vector-borne nematode diseases.

Authors:  Mostafa Zamanian; Erik C Andersen
Journal:  FEBS J       Date:  2016-07-11       Impact factor: 5.542

5.  Increasing the library size in cDNA display by optimizing purification procedures.

Authors:  Yuki Mochizuki; Shigefumi Kumachi; Koichi Nishigaki; Naoto Nemoto
Journal:  Biol Proced Online       Date:  2013-05-22       Impact factor: 3.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.